Difference between revisions of "Part:BBa K5121028"

Line 1: Line 1:
 
__NOTOC__
 
__NOTOC__
<partinfo>BBa_K5121027 short</partinfo>
+
<partinfo>BBa_K5121028 short</partinfo>
  
 
<div style="text-align: justify;">
 
<div style="text-align: justify;">

Revision as of 11:47, 2 October 2024

Reb1: RebB C-terminal LPETG

Biology

Refractile bodies, known as R bodies, are ribbon-like protein complexes produced by certain strains of bacteria. Five classes of R bodies have been described — this part specifically encodes a modified type 51 R body containing four genes; rebA, rebB, rebC, and rebD. rebA and rebB constitute the primary structural components of R bodies, while rebC is thought to aid in the polymerisation process — the function of rebD remains unknown (Heruth et al., 1994). Under basic conditions, R bodies exist in a coiled-up conformation, but will extend in a telescopic fashion under acidic conditions (Heruth et al., 1994). In nature, R bodies are produced by bacterial endosymbionts of some Paramecia. Also referred to as kappa particles, these bacteria constitute the genus Caedibacter (Beier et al., 2002). These bacterial endosymbionts confer a killer trait to host paramecia — when released and taken up by sensitive paramecia, the bacteria are exposed to an acidifying environment in the endosome (Figure 1). These conditions cause the extension of R bodies inside the bacteria, rupturing them and the endosome to release a toxin to kill the host cell (Pond et al., 1989).

Figure 1. R body mechanism in nature as illustrated by Polka and colleagues (2016). The unique ability of R bodies to burst endosomes makes them attractive candidates for nano-based drug delivery.

Part overview

Their ability to burst endosomes make R bodies appealing candidates for use in drug delivery, as they could hold the key to solving the endosomal escape problem. This composite part encodes an R body compatible with sortase A-catalysed conjugation at the C terminus of rebB — facilitating the attachment of hundreds of thousands of drug molecules down the length of assembled R bodies.

Sortase A is a bacterial transpeptidase enzyme that ligates C-terminal LPXTG motifs with N-terminal polyglycine motifs (Theile et al., 2013). Sortase A first recognises the C-terminal LPXTG motif, before cleaving the threonine-glycine peptide bond and forming a thioacyl intermediate with its active site cysteine residue. This intermediate can then be resolved via nucleophilic attack by an N-terminal polyglycine, resulting in an R1-LPXT(G)n-R2 linkage (Figure 2).

Figure 2. Sortase A reaction mechanism taken from Theile and colleagues (2013). Sortase A can be used for the conjugation of compounds — such as drugs — onto this part.

As such, to make this part sortase A-compatible, it contains an added LPETG motif at the C terminus of rebB. See the design page for more details.

Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    INCOMPATIBLE WITH RFC[12]
    Illegal NheI site found at 803
    Illegal NheI site found at 865
  • 21
    INCOMPATIBLE WITH RFC[21]
    Illegal BamHI site found at 745
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]

Characterisation

As described in the design section, overlap extension PCR was run on the purified Reb1 plasmid to add the C-terminal LPETG motif to rebB (Figure 3). Two separate PCR reactions were performed with extension times dependent on the length of each fragment. The products of each PCR reaction were run on an agarose gel to determine if the PCR was successful (Figure 4). After verifying the PCR, the remaining products were run on a new gel, from which the products were purified.

Figure 3. Plasmid map of the Reb1 plasmid. Primer targeting sites that were used to add in the rebB C-terminal LPETG motif are shown as annotations and zoomed-in alignments. Sortase A can be used for the conjugation of compounds — such as drugs — onto this part.

A Gibson assembly was prepared with the purified PCR products. The Gibson assembly products were immediately transformed into DH5-alpha E. coli cells for propagation and BL21 E. coli cells for expression. Successful Gibson assembly was indicated by the growth of colonies on plates with kanamycin. Plasmids from selected colonies were extracted and sequenced to verify they contained the correct modified rebB sequence.

Figure 4. PCR products from two fragment PCR of reb1 to introduce LPETG on the C-terminus of rebB. Each PCR reaction was set up in triplicate. Products from each reaction were run on an agarose gel. A) PCR products from the reaction with F_RebB_LPETG and R_KanR primers. The bands match the expected size of 2.2 kb. B) PCR products from the reaction with R_RebB_LPETG and F_KanR primers. The bands match the expected size of 4.7 kb. C) Successful DH5-alpha transformant containing the modified rebB-LPETG plasmid growing on kanamycin plates. A single colony was observed.

Successful expression and purification of R bodies was first confirmed by imaging the R bodies in resuspension buffer (Figure 5A). The pH of the resuspension buffer is 7.5, in which we expect the R-bodies to remain in a coiled conformation like their wild-type counterpart (BBa_K5121011). This was observed in our microscopy images of these samples. We next tested the extension behaviour of these modified R-bodies in pH 5 HCl. These R-bodies readily extend in these conditions. Further testing of their ability to retract in basic conditions could be performed in future.

Figure 5. Purification and extension testing of RebB-LPETG R bodies. A) Purified RebB-LPETG R bodies in resuspension buffer (25 mM Tris pH 7.5, 100 mM NaCl) observed at 63x under phase contrast. B) RebB-LPETG R bodies extended in pH = 5 HCl observed at 63x under phase contrast.

To characterise conjugation onto this part, mNeonGreen was used to easily verify conjugation. mNeonGreen was expressed using a pCDFDuet-1_His_mNeon_TmTP plasmid. To make mNeonGreen compatible with sortase A-catalysed conjugation, an N-terminal triglycine motif was added, preceded by a TEV protease recognition sequence to cleave off the N-terminal methionine residue. This was added using the same method as with the LPETG motif on Reb1, using primers with complementary overhangs at the mNeonGreen N-terminus, along with two additional primers with complementary overhangs targeted at either side of an unwanted signal peptide at the C-terminus of mNeonGreen (Figure 6). The modified GGG-mNeonGreen was expressed, followed by nickel-affinity purification, overnight TEV cleavage, and size exclusion chromatography. The combination of these purification techniques yielded a stock of GGG-mNeonGreen to be used for conjugation to rebA via a sortase reaction.

Figure 6. Plasmid map of the mNeonGreen plasmid along with the primer binding sites used to at modifications. A TEV recognition site followed by three glycine residues was added at the N-terminus to facilitate cleavage of the N-terminal methionine.

Several variants of the sortase enzyme are commercially available. We selected a sortase pentamutant,which was engineered via directed evolution to have 140-fold enhancements in ligation activity (Chen et al., 2011). This sortase mutant is translationally fused to an N-terminal polyhistidine tag. This tag was used to perform Ni-NTA affinity chromatography on lysates of cells overexpressing the enzyme. Lysates were incubated with the resin for 3 hours in a binding buffer (50mM Tris pH 7.5, 300mM NaCl, 10mM imidazole). The unbound lysate was collected as a flow-through sample. The resin was washed 3 times with a washing buffer (50mM Tris pH 7.5, 300mM NaCl, 20mM imidazole). Finally, bound proteins were eluted multiple times using an elution buffer (50mM Tris pH 7.5, 300mM NaCl, 500mM imidazole). Aliquots were spared at each stage and run on an SDS-PAGE gel (Figure 7A). The eluted samples were combined and dialysed overnight with the buffer for size exclusion chromatography (25 mM tris pH 7.5, 150mM NaCl). Before size exclusion chromatography (SEC), the sample was concentrated to a volume less than 5mL, suitable for input into the SEC column. The absorbance at 280 nm for each 1mL SEC fraction was measured. Fractions with peaks at the expected size of sortase were collected and run in an SDS-PAGE gel to confirm the presence of sortase A (Figure 7B). SEC visibly removed contaminants enriched during the Ni-NTA chromatography. The pure sortase A samples were then combined and concentrated, forming our stock sortase solution for subsequent conjugation reactions.

Figure 7. Purification of Sortase A pentamutant. A) Samples collected from various stages of Ni-NTA affinity purification of the his-tagged sortase enzyme. The lysate soluble fraction was loaded into the columns. The sortase enzyme was clearly enriched from the cell lysate, along with other histidine-containing proteins. B) Sortase size-exclusion chromatography (SEC) samples. The eluted samples from Ni-NTA chromatography were concentrated and subsequently purified with SEC.

We performed a conjugation test using our purified Sortase A sample, GGG-mNeonGreen and positive control substrate obtained from a member of the Structural Biology Group. The reaction was carried out with 10 µM sortase enzyme, 100 µM GGG-mNeonGreen and 100 µM LPETG-substrate, and allowed to incubate at room temperature for 1 hour before being moved to the cold room (4°C) overnight to prevent substrate degradation. The products were analysed by SDS-PAGE (Figure 8), which revealed successful conjugation - evidenced by the appearance of a higher molecular weight product at ~66 kDa, corresponding to the sum of the weights of mNeonGreen (~27 kDa) and the LPETG-substrate (38 kDa) - albeit with very low efficiency (likely <5%). Despite the low efficiency, this still confirmed that both our sortase and mNeonGreen samples appeared functional for conjugation, giving us confidence to proceed with R body conjugation trials - although with the knowledge that we would have to add a large excess of substrate in an attempt to push the equilibrium forward.

Figure 8. Sortase A (10µM) was mixed with GGG-mNeonGreen (100 µM) and CHD4(1380-1810)-LPETG (100 µM) in 1x sortase conjugation buffer. The mixture was allowed to incubate at room temperature for 1 hour, before being transferred to 4°C overnight. The reagents and products were analysed by SDS-PAGE.

Incubation of R bodies with sortase A and modified mNeonGreen led to successful conjugation of the fluorescent protein onto R bodies (see details of protocol here),as evident by the fact the pelleted R bodies were a bright green colour post-washing and the fact that R bodies observed under a microscope were also green (Figure 9). The bright green colour of the pelleted R bodies strongly suggested successful conjugation onto the R bodies, particularly given the lack of green observed in a sortase-free control sample (Figure 9A). Fluorescence microscopy of the conjugation sample verified the fluorescence was physically linked to the R bodies, confirming successful conjugation with mNeonGreen (Figure 9B).

Figure 10. Modified R bodies were conjugated with mNeonGreen, which was verified both macroscopically and microscopically. A) Washed pellets of RebB-LPETG R bodies conjugated with GGG-mNeonGreen (right) compared to a washed control pellet of RebB-LPETG R bodies (left) incubated without sortase A. B) Conjugation sample as seen with fluorescence microscopy under 63x magnification.


References

Beier, C. L., Horn, M., Michel, R., Schweikert, M., Görtz, H.-D., & Wagner, M. (2002). The Genus Caedibacter Comprises Endosymbionts of Paramecium spp. Related to the Rickettsiales (Alphaproteobacteria) and to Francisella tularensis (Gammaproteobacteria). Applied and Environmental Microbiology, 68(12), 6043–6050.

Chen, I., Dorr, B. M., & Liu, D. R. (2011). A general strategy for the evolution of bond-forming enzymes using yeast display. Proceedings of the National Academy of Sciences - PNAS, 108(28), 11399–11404.

Heruth, D. P., Pond, F. R., Dilts, J. A., & Quackenbush, R. L. (1994). Characterization of genetic determinants for R body synthesis and assembly in Caedibacter taeniospiralis 47 and 116. Journal of Bacteriology, 176(12), 3559–3567.

Polka, J. K., & Silver, P. A. (2016). A Tunable Protein Piston That Breaks Membranes to Release Encapsulated Cargo. ACS Synthetic Biology, 5(4), 303–311.

Pond, F. R., Gibson, I., Lalucat, J., & Quackenbush, R. L. (1989). R-body-producing bacteria. Microbiological Reviews, 53(1), 25–67.

Theile, C. S., Witte, M. D., Blom, A. E. M., Kundrat, L., Ploegh, H. L., & Guimaraes, C. P. (2013). Site-specific N-terminal labeling of proteins using sortase-mediated reactions. Nature Protocols, 8(9), 1800–1807.